We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$811M
Cap. Flow
+$429M
Cap. Flow %
2.05%
Top 10 Hldgs %
15.16%
Holding
2,330
New
84
Increased
1,228
Reduced
936
Closed
75

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$42M
2
VZ icon
Verizon
VZ
+$41.3M
3
NEE icon
NextEra Energy
NEE
+$28.9M
4
CHL
China Mobile Limited
CHL
+$24M
5
AMZN icon
Amazon
AMZN
+$22.3M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$48.9M
2
MON
Monsanto Co
MON
+$40.2M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
MMM icon
3M
MMM
+$26.7M
5
IBM icon
IBM
IBM
+$24M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Financials 17.23%
3 Healthcare 12.98%
4 Consumer Discretionary 10.12%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
26
Wells Fargo
WFC
$254B
$108M 0.52%
1,943,770
+23,525
+1% +$1.26M
TXN icon
27
Texas Instruments
TXN
$248B
$101M 0.48%
917,714
+54,769
+6% +$5.93M
ACN icon
28
Accenture
ACN
$106B
$98.9M 0.47%
604,749
+24,539
+4% +$3.82M
DIS icon
29
Walt Disney
DIS
$171B
$98.8M 0.47%
942,871
+23,516
+3% +$2.4M
MRK icon
30
Merck
MRK
$322B
$97M 0.46%
1,674,612
+175,508
+12% +$9.9M
C icon
31
Citigroup
C
$213B
$96.4M 0.46%
1,440,186
-30,758
-2% -$2.12M
ABBV icon
32
AbbVie
ABBV
$465B
$94.8M 0.45%
1,023,077
+31,738
+3% +$3.1M
PG icon
33
Procter & Gamble
PG
$340B
$93.7M 0.45%
1,199,768
-360,383
-23% -$27.1M
CMCSA icon
34
Comcast
CMCSA
$87.3B
$92.9M 0.44%
2,830,895
+42,823
+2% +$1.4M
NVDA icon
35
NVIDIA
NVDA
$4.6T
$91.9M 0.44%
15,515,400
+441,560
+3% +$2.68M
MCD icon
36
McDonald's
MCD
$193B
$91.7M 0.44%
585,416
+19,727
+3% +$3.2M
NFLX icon
37
Netflix
NFLX
$307B
$89.7M 0.43%
2,292,250
+101,550
+5% +$3.46M
MMM icon
38
3M
MMM
$91.8B
$89.2M 0.43%
542,010
-156,639
-22% -$26.7M
KO icon
39
Coca-Cola
KO
$383B
$86.8M 0.41%
1,979,542
-162,895
-8% -$7.04M
AMGN icon
40
Amgen
AMGN
$209B
$86.6M 0.41%
469,329
+21,376
+5% +$3.78M
ORCL icon
41
Oracle
ORCL
$339B
$85.7M 0.41%
1,945,294
-38,014
-2% -$1.75M
HON icon
42
Honeywell
HON
$76.4B
$84.4M 0.4%
648,321
-6,889
-1% -$917K
UNP icon
43
Union Pacific
UNP
$174B
$82.5M 0.39%
582,359
+29,767
+5% +$4.15M
TJX icon
44
TJX Companies
TJX
$179B
$82M 0.39%
1,722,024
+422,594
+33% +$18.6M
TMO icon
45
Thermo Fisher Scientific
TMO
$214B
$81.4M 0.39%
393,129
+765
+0.2% +$162K
RDS.A
46
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$80.4M 0.38%
1,161,941
+22,690
+2% +$1.57M
TSM icon
47
TSMC
TSM
$1.94T
$80.3M 0.38%
2,196,321
-96,914
-4% -$3.83M
NKE icon
48
Nike
NKE
$64.1B
$77.9M 0.37%
977,092
+38,414
+4% +$2.71M
ADBE icon
49
Adobe
ADBE
$105B
$77.7M 0.37%
318,661
+30,952
+11% +$7.32M
DD icon
50
DuPont de Nemours
DD
$18.6B
$74.3M 0.36%
445,226
+1,664
+0.4% +$279K

Similar funds

Aperio Group's Q2 2018 Portfolio in Review

As of Q2 2018, Aperio Group held 2,330 positions worth $20.9B, up 4% from $20.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q2 2018 filing shows 84 new, 1,228 increased, 936 reduced and 75 closed positions. Its largest new stake was Evergy: 203,701 shares worth $11.4M. The largest sale was Time Warner Inc, an estimated $48.9M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q2 2018 buy was Evergy: 203,701 shares worth $11.4M.
  • Aperio Group added most to Pfizer in Q2 2018, an estimated $42M increase.
  • Aperio Group's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $27.1M.
  • Aperio Group fully exited Time Warner Inc in Q2 2018, selling an estimated $48.9M.
  • Aperio Group's ten largest holdings make up 15% of its $20.9B portfolio in Q2 2018.
  • Aperio Group opened 84 new positions and closed 75 in Q2 2018.
  • Aperio Group's portfolio value rose 4% quarter-over-quarter to $20.9B.

Based on Aperio Group's 13F filing for Q2 2018, filed 30 Jul 2018.